| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $8.0M | +10.9% |
| SG&A Expense | $12.9M | +82.6% |
| Operating Income | -$20.9M | -46.4% |
| Pre-tax Income | -$20.4M | -46.9% |
| Net Income | -$20.4M | -46.9% |
| EPS (Basic) | -$2.91 | +77.1% |
| EPS (Diluted) | -$2.91 | +77.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.2M | +696.8% |
| Current Assets | $56.5M | +666.2% |
| Total Assets | $60.2M | +275.0% |
| Current Liabilities | $5.0M | +344.2% |
| Total Liabilities | $5.0M | +291.6% |
| Stockholders' Equity | $55.2M | +273.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.2M | -9.3% |
| Investing Cash Flow | $11K | — |
| Financing Cash Flow | $63.5M | +1306.0% |